Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 120

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

DNA Damage and the Activation of the p53 Pathway Mediate Alterations in Metabolic and Secretory Functions of Adipocytes

Vergoni, Bastien, Cornejo, Pierre-Jean, Gilleron, Jérôme, Djedaini, Mansour, Ceppo, Franck, Jacquel, Arnaud, Bouget, Gwennaelle, Ginet, Clémence, Gonzalez, Teresa, Maillet, Julie, Dhennin, Véronique, Verbanck, Marie, Auberger, Patrick, Froguel, Philippe, Tanti, Jean-François, Cormont, Mireille · 2016 · Diabetes

Abstract

Activation of the p53 pathway in adipose tissue contributes to insulin resistance associated with obesity. However, the mechanisms of p53 activation and the effect on adipocyte functions are still elusive. Here we found a higher level of DNA oxidation and a reduction in telomere length in adipose tissue of mice fed a high-fat diet and an increase in DNA damage and activation of the p53 pathway in adipocytes. Interestingly, hallmarks of chronic DNA damage are visible at the onset of obesity. Furthermore, injection of lean mice with doxorubicin, a DNA damage-inducing drug, increased the expression of chemokines in adipose tissue and promoted its infiltration by proinflammatory macrophages and neutrophils together with adipocyte insulin resistance. In vitro, DNA damage in adipocytes increased the expression of chemokines and triggered the production of chemotactic factors for macrophages and neutrophils. Insulin signaling and effect on glucose uptake and Glut4 translocation were decreased, and lipolysis was increased. These events were prevented by p53 inhibition, whereas its activation by nutlin-3 reproduced the DNA damage-induced adverse effects. This study reveals that DNA damage in obese adipocytes could trigger p53-dependent signals involved in alteration of adipocyte metabolism and secretory function leading to adipose tissue inflammation, adipocyte dysfunction, and insulin resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db16-0014

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 33

  1. Kahn, 2000, Obesity and insulin resistance, J Clin Invest, 106, 473, 10.1172/JCI10842 · DOI · Paper page
  2. Herman, 2006, Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony, J Clin Invest, 116, 1767, 10.1172/JCI29027 · DOI · Paper page
  3. Hotamisligil, 2006, Inflammation and metabolic disorders, Nature, 444, 860, 10.1038/nature05485 · DOI · Paper page
  4. Hafsi, 2011, Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence, Antioxid Redox Signal, 15, 1655, 10.1089/ars.2010.3771 · DOI
  5. Hallenborg, 2009, The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function, Expert Opin Ther Targets, 13, 235, 10.1517/14712590802680141 · DOI
  6. Schupp, 2013, Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues, BMC Genomics, 14, 758, 10.1186/1471-2164-14-758 · DOI
  7. Yahagi, 2003, p53 Activation in adipocytes of obese mice, J Biol Chem, 278, 25395, 10.1074/jbc.M302364200 · DOI · Paper page
  8. Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat Med, 15, 1082, 10.1038/nm.2014 · DOI · Paper page
  9. Phillips, 2007, DNA double-strand break repair and development, Oncogene, 26, 7799, 10.1038/sj.onc.1210877 · DOI
  10. Kaddai, 2009, Involvement of TNF-alpha in abnormal adipocyte and muscle sortilin expression in obese mice and humans, Diabetologia, 52, 932, 10.1007/s00125-009-1273-3 · DOI
  11. Jager, 2010, Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-alpha effects on extracellular signal-regulated kinase activation and lipolysis, Diabetes, 59, 61, 10.2337/db09-0470 · DOI
  12. Jager, 2011, Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity, Diabetologia, 54, 180, 10.1007/s00125-010-1944-0 · DOI
  13. Mari, 2006, The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes, J Cell Sci, 119, 1297, 10.1242/jcs.02850 · DOI
  14. Gilleron, 2013, Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape, Nat Biotechnol, 31, 638, 10.1038/nbt.2612 · DOI · Paper page
  15. Renier, 2014, iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging, Cell, 159, 896, 10.1016/j.cell.2014.10.010 · DOI · Paper page
  16. Ritchie, 2015, limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res, 43, e47, 10.1093/nar/gkv007 · DOI · Paper page
  17. Kaddai, 2008, The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes, Am J Physiol Endocrinol Metab, 295, E162, 10.1152/ajpendo.00622.2007 · DOI
  18. Dizdaroglu, 2012, Mechanisms of free radical-induced damage to DNA, Free Radic Res, 46, 382, 10.3109/10715762.2011.653969 · DOI · Paper page
  19. Arner, 2014, Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance, Trends Endocrinol Metab, 25, 255, 10.1016/j.tem.2014.03.002 · DOI · Paper page
  20. Tanaka, 2015, Adipocyte-specific disruption of fat-specific protein 27 causes hepatosteatosis and insulin resistance in high-fat diet-fed mice, J Biol Chem, 290, 3092, 10.1074/jbc.M114.605980 · DOI
  21. Ortega, 2014, Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression, Int J Obes, 38, 737, 10.1038/ijo.2013.163 · DOI
  22. Yokoyama, 2014, Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity, Cell Rep, 7, 1691, 10.1016/j.celrep.2014.04.046 · DOI · Paper page
  23. Inoue, 2008, Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance, J Biol Chem, 283, 21220, 10.1074/jbc.M801824200 · DOI
  24. Eriksson, 2007, Metabolic stress in insulin’s target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance, FEBS Lett, 581, 3734, 10.1016/j.febslet.2007.06.044 · DOI · Paper page
  25. Vieira-Potter, 2014, Inflammation and macrophage modulation in adipose tissues, Cell Microbiol, 16, 1484, 10.1111/cmi.12336 · DOI · Paper page
  26. Chatzinikolaou, 2014, DNA damage and innate immunity: links and trade-offs, Trends Immunol, 35, 429, 10.1016/j.it.2014.06.003 · DOI
  27. Surmi, 2010, The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue, Vascul Pharmacol, 52, 27, 10.1016/j.vph.2009.12.004 · DOI
  28. Huh, 2014, Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity, Mol Cells, 37, 365, 10.14348/molcells.2014.0074 · DOI · Paper page
  29. Ceppo, 2014, Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages, Endocrinology, 155, 951, 10.1210/en.2013-1815 · DOI
  30. Shimizu, 2013, Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity, Cell Metab, 18, 491, 10.1016/j.cmet.2013.09.001 · DOI
  31. Girousse, 2013, Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass, PLoS Biol, 11, e1001485, 10.1371/journal.pbio.1001485 · DOI · Paper page
  32. Herman, 2012, A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism, Nature, 484, 333, 10.1038/nature10986 · DOI · Paper page
  33. Roberts, 2009, Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans, Diabetologia, 52, 882, 10.1007/s00125-009-1300-4 · DOI · Paper page

Cited by

See all 120

Metadata

Authors
Vergoni, B., Cornejo, P.-J., Gilleron, J., Djedaini, M., Ceppo, F., Jacquel, A., Bouget, G., Ginet, C., Gonzalez, T., Maillet, J., Dhennin, V., Verbanck, M., Auberger, P., Froguel, P., Tanti, J.-F., & Cormont, M.
Venue
Diabetes
Published
2016-07-07
Volume
65
Issue
10
Pages
3062-3074
ISSN
  • 0012-1797
  • 1939-327X
Cited by
120
References
12
Language
en
Funders
  • European Foundation for the Study of Diabetes (EFSD/Lilly)
  • Aviesan (Diabetes and the Vessel Wall Injury Program, LabexEGID (European Genomics Institute for Diabetes, ANR-10-LABX-46)
  • ANR (ANR-10-EQPX-07-01, “LIGAN-PM”, postdoctoral grant)
  • “Fondation pour la Recherche Médicale”
  • INSERM/Région PACA/FEDER (PhD grant)
  • Société Francophone du Diabète ((SF, D/Abbott, Labex SIGNALIFE grant (ANR-11-LABX-0028-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.